Artificial Intelligence in Prostate Cancer Videos

CHHiP Trial Evaluates a Multimodal AI Biomarker in Localized Prostate Cancer - Anna Wilkins

Study Explores Biologic Pathways Underlying AI-Based Biomarker in Oligometastatic Prostate Cancer - Amol Shetty

Study Investigates an AI-Powered Prognostic Test in Salvage Radiation Therapy Patients - Paul Nguyen

AI Model Identifies STAMPEDE Patients Needing Treatment Intensification - Nicholas James

Multimodal AI Test Predicts Prostate Cancer Metastasis and Treatment Response - Timothy Showalter

MMAI Score Prognostic for Overall Survival in Oligometastatic Castration-Sensitive Prostate Cancer - Phuoc Tran & Tim Showalter

AI-Powered Prostate Cancer Risk Assessment Tool Validated for Low-risk and Active Surveillance - Andre Esteva

MMAI Model Risk Stratification for NCCN Guidelines for Low, Intermediate, and High-Risk Prostate Cancer - Neal Shore, Daniel Spratt, & Alicia Morgans

Predicting Response to Hormone Therapy in Prostate Cancer With a Post-Prostatectomy MMAI Model - Todd Morgan

The Artera AI Model: Advancing Personalized Medicine in Prostate Cancer Treatment | Dan Spratt & Alicia Morgans Discuss NEJM Evidence Manuscript

Personalizing Prostate Cancer Therapy Using AI-based Predictive Biomarkers - Paul Nguyen

Artera Multi-Modal AI Platform - Guiding Treatment Decisions in Men with Prostate Cancer - Andre Esteva & Felix Feng

Beyond the NCCN Localized Prostate Cancer Risk Category: The MMAI Prognostic Risk Stratification Model - Jonathan Tward

Multi-Modal Artificial Intelligence (MMAI) Prognostic Biomarker in High-Risk Prostate Cancer - Daniel Spratt

Artificial Intelligence Transformative in Prostate Cancer Patient Care - Felix Feng

Who is ARTERA? - Andre Esteva

Beyond Genomics: AI Informing Decision Making in Prostate Cancer – Ashley Ross